2seventy bio's market cap is currently $123.30M. The company's EPS TTM is $-1.855; its P/E ratio is ―; 2seventy bio is scheduled to report earnings on March 25, 2025, and the estimated EPS forecast is $-0.20. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 100.39M	$ 91.50M	$ 54.52M	$ 248.12M	$ 44.30M
Gross Profit	$ 83.47M	$ 65.28M	$ 41.93M	$ 242.73M	$ 41.32M
Operating Income	$ -216.70M	$ -262.91M	$ -313.51M	$ -144.64M	$ -337.97M
EBITDA	$ -206.42M	$ -251.38M	$ -297.16M	$ -131.45M	$ -329.19M
Net Income	$ -217.57M	$ -254.14M	$ -276.21M	$ -138.17M	$ -323.34M
Balance Sheet
Cash & Short-Term Investments	$ 216.99M	$ 266.27M	$ 362.18M	$ -127.60M	$ -133.57M
Total Assets	$ 565.43M	$ 656.66M	$ 759.67M	$ 312.62M	$ 314.95M
Total Debt	$ 256.67M	$ 270.17M	$ 282.21M	$ 127.60M	$ 133.57M
Net Debt	$ 181.72M	$ 199.14M	$ 151.80M	$ 255.21M	$ 267.15M
Total Liabilities	$ 310.13M	$ 346.20M	$ 399.85M	$ 237.99M	$ 271.26M
Stockholders' Equity	$ 255.30M	$ 310.47M	$ 359.82M	$ 74.63M	$ 43.69M
Cash Flow
Free Cash Flow	$ -180.72M	$ -259.98M	$ -226.61M	$ -90.05M	$ -267.72M
Operating Cash Flow	$ -166.86M	$ -237.13M	$ -207.03M	$ -67.79M	$ -207.96M
Investing Cash Flow	$ 43.86M	$ 11.70M	$ 15.41M	$ -22.26M	$ -59.77M
Financing Cash Flow	$ 127.39M	$ 166.23M	$ 354.89M	$ 90.05M	$ 267.72M

Currency in USD

2seventy bio Earnings and Revenue History

Income Statement >

2seventy bio Debt to Assets

Balance Sheet >

2seventy bio Cash Flow

Cash Flow >

2seventy bio Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing